Patents by Inventor Michael Jensen
Michael Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230296530Abstract: A seed sampling system is provided comprising an automated seed loading assembly operable to singulate seeds from a plurality of seeds or enable loading of individually stored seeds and an automated seed sampling assembly comprising at least one sampling module operable to remove tissue samples from one of the singulated seeds. The system also includes an automated seed transport assembly comprising at least one retention member operable to transfer the singulated seeds from at least one elevator unit of the seed loading assembly to the at least one sampling module of the seed sampling assembly. In connection therewith, the at least one sampling module includes multiple sampling locations, each associated with a sampler, where the at least one sampling module is operable to remove tissue samples from seeds at one of sampling locations while another one of the sampling locations is cleaned to remove residual seed tissue therefrom.Type: ApplicationFiled: May 23, 2023Publication date: September 21, 2023Inventors: Wayne BROWN, Michael Joseph DAYAWON, David FINLEY, William Michael FISCHER, Yang Ju IM, John Michael JENSEN, Jeffrey Lawrence KOHNE, Matthew J. WEIS
-
Publication number: 20230227551Abstract: The invention is directed to a bispecific chimeric antigen receptor, comprising: (a) at least two antigen-specific targeting regions; (b) an extracellular spacer domain; (c) a transmembrane domain; (d) at least one co-stimulatory domain; and (e) an intracellular signaling domain, wherein each antigen-specific targeting region comprises an antigen-specific single chain Fv (scFv) fragment, and binds a different antigen, and wherein the bispecific chimeric antigen receptor is co-expressed with a therapeutic control. The invention also provides methods and uses of the bispecific chimeric antigen receptors.Type: ApplicationFiled: January 31, 2023Publication date: July 20, 2023Applicant: Seattle Children's Hospital d/b/a Seattle Children's Research InstituteInventor: Michael Jensen
-
Patent number: 11698345Abstract: A seed sampling system is provided comprising an automated seed loading assembly operable to singulate seeds from a plurality of seeds or enable loading of individually stored seeds and an automated seed sampling assembly comprising at least one sampling module operable to remove tissue samples from one of the singulated seeds. The system also includes an automated seed transport assembly comprising at least one retention member operable to transfer the singulated seeds from at least one elevator unit of the seed loading assembly to the at least one sampling module of the seed sampling assembly. In connection therewith, the at least one sampling module includes multiple sampling locations, each associated with a sampler, where the at least one sampling module is operable to remove tissue samples from seeds at one of sampling locations while another one of the sampling locations is cleaned to remove residual seed tissue therefrom.Type: GrantFiled: June 19, 2018Date of Patent: July 11, 2023Assignee: MONSANTO TECHNOLOGY LLCInventors: Wayne Brown, Michael Joseph Dayawon, David W. Finley, William Michael Fischer, Yang Ju Im, John Michael Jensen, Jeffrey Lawrence Kohne, Matthew J. Weis
-
Publication number: 20230202556Abstract: An adjustable steering stop includes a chassis stop configured to be coupled to a chassis member of a vehicle and a knuckle stop configured to be coupled to a steering knuckle. The chassis stop and the knuckle stop together define a steering limit location where the knuckle stop contacts the chassis stop. The adjustable steering stop further includes an adjustment actuator coupled to one of the chassis stop or the knuckle stop to move the chassis stop or the knuckle stop thereby changing the steering limit location.Type: ApplicationFiled: December 23, 2021Publication date: June 29, 2023Applicant: CNH Industrial America LLCInventors: Daniel Payne, Michael Jensen
-
Publication number: 20230180799Abstract: The coating can have a low-sweetness perception. During manufacturing and processing, the coating maintains a flowability to allow a glaze state of the coating to be applied to a food. Upon cooling, the glaze state of the coating forms a glass state that provides a low-sweetness impact which facilitates application of savory taste perceptions.Type: ApplicationFiled: September 19, 2022Publication date: June 15, 2023Inventors: Michael Jensen, Jenny Viviana Bermudez Lopez, Kirsten Fletter, Jacqueline Mathews, Clinton L. Johnson
-
Patent number: 11675969Abstract: Approaches, techniques, and mechanisms are disclosed for automatically inserting supplemental items into documents. According to an embodiment, a first request is received, comprising document information that identifies a particular document. A target repeated structure type, to which a group of items in the particular document conform, is identified within the particular document. Based on the target repeated structure type, a template is generated. A new content item is generated by applying descriptive metadata that describes the new content item to the template. The new content item conforms to the target repeated structure type. The new content item is inserted in the particular document at an insertion point before or after a particular content item that conforms to the target repeated structure type.Type: GrantFiled: October 25, 2021Date of Patent: June 13, 2023Assignee: Sharethrough Inc.Inventors: Ryan Weald, Michael Jensen
-
Patent number: 11648351Abstract: The present invention provides a power unit (1) for a drug delivery device as well as methods for providing and mounting the power unit (1) in the drug delivery device. The power unit (1) comprises a first interface member (30) extending along a reference axis and comprising a hollow body (31) and a first engagement structure (35), a second interface member (10) comprising a tubular structure (11) extending at least partially through the hollow body (31) and having a skirt (12), and a second engagement structure (14) configured for releasable engagement with the first engagement structure (35), and a torsion spring (20) comprising a first end portion (23) being attached to the first interface member (30) and a second end portion (22) being attached to the second interface member (10), the torsion spring (20) being pre-strained to induce a relative rotational motion between the first interface member (30) and the second interface member (10).Type: GrantFiled: November 20, 2018Date of Patent: May 16, 2023Assignee: Novo Nordisk A/SInventors: Noekkvi Steinn Sigurdarson, Nicolai Michael Jensen
-
Patent number: 11639387Abstract: The invention is directed to a bispecific chimeric antigen receptor, comprising: (a) at least two antigen-specific targeting regions; (b) an extracellular spacer domain; (c) a transmembrane domain; (d) at least one co-stimulatory domain; and (e) an intracellular signaling domain, wherein each antigen-specific targeting region comprises an antigen-specific single chain Fv (scFv) fragment, and binds a different antigen, and wherein the bispecific chimeric antigen receptor is co-expressed with a therapeutic control. The invention also provides methods and uses of the bispecific chimeric antigen receptors.Type: GrantFiled: September 29, 2020Date of Patent: May 2, 2023Assignee: Seattle Children's HospitalInventor: Michael Jensen
-
Patent number: 11633540Abstract: The present invention concerns a drug delivery device (1) comprising: a housing (2) extending along a main axis, a torsion spring (5) comprising a first spring end (4) arranged stationarily with respect to the housing (2) and a second spring end (6) capable of rotation about the main axis, a rotatable shaft (80) extending along the main axis, the rotatable shaft (80) having a non-self-locking thread (81) and being axially fixed with respect to the housing (2), a spring end retainer (82) to which the second spring end (6) is attached, the spring end retainer (82) being rotationally fixed relative to the rotatable shaft (80), and a nut member (45) engaged with the non-self-locking thread (81), the nut member (45) being axially movable by translation relative to the housing (2) to thereby travel the non-self-locking thread (81) between a first position in which the torsion spring (5) is in a relaxed state and a second position in which the torsion spring (5) is in a strained state.Type: GrantFiled: December 4, 2018Date of Patent: April 25, 2023Assignee: Novo Nordisk A/SInventors: Noekkvi Steinn Sigurdarson, Nicolai Michael Jensen
-
Patent number: 11602966Abstract: A work vehicle includes a chassis. An independent linear suspension system couples to the chassis. The independent linear suspension system includes a driveshaft that couples to the chassis and to a transmission. A wheel hub couples to the driveshaft and rotates a wheel in response to rotation of the driveshaft. A spindle couples to the wheel hub. A spindle carrier couples to the spindle. The spindle carrier defines a first aperture and a second aperture. A first pin extends through the first aperture. A second pin extends through the second aperture. The first pin and the second pin block rotation of the spindle carrier. The spindle carrier moves linearly along the first pin and the second pin.Type: GrantFiled: June 25, 2021Date of Patent: March 14, 2023Assignee: CNH Industrial America LLCInventors: Thomas T. Yi, Michael Jensen
-
Publication number: 20230050022Abstract: Described herein are aptamers that bind to the transferrin receptor (e.g., CD71) and can be used, in part, for depleting transferrin receptor-expressing cells from a population of therapeutic cells. These aptamer compositions can be used in methods for isolating and/or enriching cells expressing CD71 or depleting cell populations of cells expressing CD71, including for example, tumor cells. Further provided are methods of using the aptamers or cell populations generated using them in the methods disclosed herein for therapies and/or drug delivery.Type: ApplicationFiled: July 15, 2022Publication date: February 16, 2023Applicants: University of Washington, Seattle Children's Hospital d/b/a Seattle Children's Research InstituteInventors: Suzie Hwang Pun, Nataly Kacherovsky, Emmeline Cheng, Ian Cardle, Michael Jensen
-
Publication number: 20230042315Abstract: The present disclosure relates to devices, methods, and computer-readable medium for providing recommendations for alternate resources to use for cloud services. The devices, methods, and computer-readable medium may receive a resource allocation request for a new resource of a computing system and may predict an occurrence of a capacity related allocation for the resource allocation request. The devices, methods, and computer-readable medium may identify alternate resources to use for the resource allocation request and may provide recommendations with the alternate resources.Type: ApplicationFiled: October 25, 2022Publication date: February 9, 2023Inventors: Gowri BHASKARA, Wei ZOU, Brent Michael JENSEN, Ahmed Ragab Nabhan MOSTAFA, Bhaumik CHOKSHI, Zainab HAKIM, Shanti KEMBURU, Ning LIU, Benjamin Walter MARTENS, Nicholas Anthony SWANSON
-
Patent number: 11518814Abstract: Provided are methods for preventing or ameliorating toxicity caused by or due to a therapy, such as an immunotherapy or a cell therapy, by pre-emptive or early administration toxicity-targeting agent(s). In some embodiments, the therapy is a cell therapy in which the cells generally express recombinant receptors such as chimeric receptors, e.g., chimeric antigen receptors (CARs) or other transgenic receptors such as T cell receptors (TCRs). Features of the methods, including the timing of the administration of the agents or treatments for toxicity, provide various advantages, such as lower toxicity while maintaining persistence and efficacy of the administered cells.Type: GrantFiled: March 22, 2017Date of Patent: December 6, 2022Assignee: SEATTLE CHILDREN'S HOSPITALInventors: Michael Jensen, Rebecca Gardner
-
Patent number: 11501227Abstract: The present disclosure relates to devices, methods, and computer-readable medium for providing recommendations for alternate resources to use for cloud services. The devices, methods, and computer-readable medium may receive a resource allocation request for a new resource of a computing system and may predict an occurrence of a capacity related allocation for the resource allocation request. The devices, methods, and computer-readable medium may identify alternate resources to use for the resource allocation request and may provide recommendations with the alternate resources.Type: GrantFiled: December 9, 2019Date of Patent: November 15, 2022Assignee: MICROSOFT TECHNOLOGY LICENSING, LLCInventors: Gowri Bhaskara, Wei Zou, Brent Michael Jensen, Ahmed Ragab Nabhan Mostafa, Bhaumik Chokshi, Zainab Hakim, Shanti Kemburu, Ning Liu, Benjamin Walter Martens, Nicholas Anthony Swanson
-
Patent number: 11478002Abstract: The coating can have a low-sweetness perception. During manufacturing and processing, the coating maintains a flowability to allow a glaze state of the coating to be applied to a food. Upon cooling, the glaze state of the coating forms a glass state that provides a low-sweetness impact which facilitates application of savory taste perceptions.Type: GrantFiled: June 15, 2020Date of Patent: October 25, 2022Assignee: Conagra Foods RDM, Inc.Inventors: Michael Jensen, Jenny V. Bermudez Lopez, Kirsten Fletter, Jacqueline Mathews, Clinton L. Johnson
-
Patent number: 11454323Abstract: A sealing system includes a shaft seal plate, a seal guide having a tab, and a shaft seal coupled to the seal guide. A guide slot is formed in the shaft seal plate, and the tab extends into the guide slot. The shaft seal is configured to form and substantially maintain a seal at an axle bar as the axle bar rotates and pivots. The seal guide is configured to translate relative to the shaft seal plate as the axle bar pivots, and the tab is configured to block a rotation of the seal guide and the shaft seal relative to the shaft seal plate as the axle bar rotates.Type: GrantFiled: December 4, 2018Date of Patent: September 27, 2022Assignee: CNH Industrial America LLCInventors: Michael Jensen, Daniel Payne
-
Publication number: 20220156451Abstract: Approaches, techniques, and mechanisms are disclosed for automatically inserting supplemental items into documents. According to an embodiment, a first request is received, comprising document information that identifies a particular document. A target repeated structure type, to which a group of items in the particular document conform, is identified within the particular document. Based on the target repeated structure type, a template is generated. A new content item is generated by applying descriptive metadata that describes the new content item to the template. The new content item conforms to the target repeated structure type. The new content item is inserted in the particular document at an insertion point before or after a particular content item that conforms to the target repeated structure type.Type: ApplicationFiled: October 25, 2021Publication date: May 19, 2022Inventors: Ryan Weald, Michael Jensen
-
Publication number: 20220111687Abstract: An axle assembly includes a connection assembly having a stationary portion and a rotary portion. The stationary portion is configured to couple to an inlet airflow assembly configured to be non-movably coupled to a beam housing, the rotary portion is configured to couple to an outlet airflow assembly configured to be non-movably coupled to a steering knuckle, the stationary portion forms a cavity configured to facilitate flow of pressurized air from the inlet airflow assembly to the rotary portion, and the rotary portion forms an airflow path configured to facilitate flow of the pressurized air from the cavity to the outlet airflow assembly.Type: ApplicationFiled: October 7, 2021Publication date: April 14, 2022Inventors: Jie Tu, Michael Jensen
-
Patent number: 11278594Abstract: The present invention relates to chimeric transmembrane immunoreceptors, named “zetakines,” comprised of an extracellular domain comprising a soluble receptor ligand linked to a support region capable of tethering the extracellular domain to a cell surface, a transmembrane region and an intracellular signalling domain. Zetakines, when expressed on the surface of T lymphocytes, direct T cell activity to those specific cells expressing a receptor for which the soluble receptor ligand is specific. Zetakine chimeric immunoreceptors represent a novel extension of antibody-based immunoreceptors for redirecting the antigen specificity of T cells, with application to treatment of a variety of cancers, particularly via the autocrin/paracrine cytokine systems utilized by human malignancy.Type: GrantFiled: December 20, 2019Date of Patent: March 22, 2022Assignee: City of HopeInventor: Michael Jensen
-
Publication number: 20220001710Abstract: A work vehicle includes a chassis. An independent linear suspension system couples to the chassis. The independent linear suspension system includes a driveshaft that couples to the chassis and to a transmission. A wheel hub couples to the driveshaft and rotates a wheel in response to rotation of the driveshaft. A spindle couples to the wheel hub. A spindle carrier couples to the spindle. The spindle carrier defines a first aperture and a second aperture. A first pin extends through the first aperture. A second pin extends through the second aperture. The first pin and the second pin block rotation of the spindle carrier. The spindle carrier moves linearly along the first pin and the second pin.Type: ApplicationFiled: June 25, 2021Publication date: January 6, 2022Inventors: Thomas T. Yi, Michael Jensen